Also see the Open Notebook Science info at: Accelerating - Open Notebook Science

Critical Path Management:

Wikipedia explanation:

Clinical Methods:

Power of Rare Diseases: Found in Translation - Mark Fishman - Science and Translational Medicine - 9/4/2013:

From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients. November 2014:

Breaking Down Translation Barriers Investigator’s Perspective Nathan P. Staf , Bethany Kinseth Runge, Anthony J. Windebank 9-3-2014:

Open Notebook Science:

9/20/2013 Article:
Secretive and Subjective, Peer Review Proves Resistant to Study - Science Magazine - Jennifer Couzin-Frankel:Secretive and subjective, peer review proves resistant to study - 9-20-13-Sciencemag.pdf

6/5/2013 Press Release:
Research organizations agree to share genetic data:
The NIH has joined about 70 medical, research and advocacy organizations across the globe in an initiative to create a shared database of genetic and clinical information. The coalition will agree on standards for representing and sharing genetic data as well as for obtaining patient consent. Researchers hope pooled data will allow them to understand and treat rare genetic mutations in cancer, pediatric diseases, heart disease and other conditions. Nature (free content)/News blog (6/5/2013)

6/10/2013 Press Release:

Bill Gates and Tenaya Capital Invest in ResearchGate to Advance Scientific Innovation Through Open Science
Dragoneer Investment Group, Thrive Capital, and existing investors Benchmark and Founders Fund join to fuel growth with 35 million USD Series C

Berlin, Germany and Cambridge, MA, USA – June 4, 2013 – ResearchGate, the professional network for scientists, today announced a new investment from Bill Gates and Tenaya Capital with participation from Dragoneer Investment Group, Thrive Capital, and the company's existing investors Benchmark and Founders Fund. Backed by this growth investment of 35 million USD, ResearchGate will continue to lead the research community into the open science era by removing archaic silos of science to intelligently connect scientists, data, and resources.

"Our goal is to free knowledge from the ivory tower, to digitalize it, and make it accessible for everyone in order to accelerate scientific progress," said Ijad Madisch, co-founder and CEO of ResearchGate. "With Bill Gates and Tenaya Capital, we're excited to add to our group of investors whose goals are perfectly in line with ours, and who understand the relevance of what we are doing – not only for science, but for society. To ensure everyone has the possibility to lead a healthy and productive life, science has to come up with new solutions to eradicate diseases and spread new knowledge quickly and effectively. We are building the digital infrastructure to make this happen."
The new financing will help spur further innovation in the fields of sharing and searching for scientific data online, including raw data and data from failed experiments. ResearchGate is also improving the way scientific reputation is measured.

Ben Boyer, Managing Director of Tenaya Capital said: "ResearchGate not only has the opportunity to influence the trillion dollars spent yearly on research and development but – through scientific breakthroughs enabled by the network's knowledge share – impact the world as a whole."

"Just as I witnessed at LinkedIn and Facebook, a true network effect business like ResearchGate has the power to change the world," said Benchmark General Partner Matt Cohler, who led the Series A investment and is a member of the board. "With ResearchGate's growing network of more than 2.9 million members, we are just beginning to see the transformative impact of removing the arcane barriers to scientific collaboration and sharing. We're thrilled to welcome Bill Gates and Tenaya as ResearchGate enters its next phase of growth."

About ResearchGate
ResearchGate was founded in 2008 by physicians Dr. Ijad Madisch and Dr. Sören Hofmayer, and computer scientist Horst Fickenscher. Five years later, more than 2.9 million researchers publish their findings, distribute them worldwide, and make a name for themselves on ResearchGate. The company has completed three rounds of financing from Benchmark, Founders Fund, Bill Gates, and Tenaya Capital.
Read more: Bill Gates and Tenaya Capital Invest in ResearchGate to Advance Scientific Innovation Through Open Science - FierceBiotech
Subscribe at FierceBiotech